0.015 (3.06%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Very Strong
Earnings
Strong
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Very Weak
Website
Recce Pharmaceuticals Ltd.
Telephone
61.2.9000.1907
Address
Level 15, Governor Macquarie Tower, 1 Farrer Place, Sydney, New South Wales (NSW) 2000
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.28 - 0.73
Trade Value (12mth)
AU$14,373.00
1 week
2.08%
1 month
-10.09%
YTD
-26.59%
1 year
68.97%
All time high
1.84
EPS 3 yr Growth
46.00%
EBITDA Margin
0.00%
Operating Cashflow
-$20m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-21.90
Quick Ratio
1.90
Shares Outstanding (Fully Diluted)
289m
HALO Sector
Healthcare
Next Company Report Date
28-Aug-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 30 April 26 | |
| 21 April 26 | |
| 15 April 26 | |
| 27 February 26 | |
| 24 February 26 |
Historical data
Forecast data
| AUD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.07 | -0.1 | -0.09 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.07 | -0.1 | -0.09 | | | | ||
Growth | % | | | | | -19.1 | -34.1 | 8.5 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Months Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
